110 related articles for article (PubMed ID: 2375908)
1. HLA class I expression on erythrocytes and platelets from patients with systemic lupus erythematosus, rheumatoid arthritis and from normal subjects.
Botto M; So AK; Giles CM; Mason PD; Walport MJ
Br J Haematol; 1990 May; 75(1):106-11. PubMed ID: 2375908
[TBL] [Abstract][Full Text] [Related]
2. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
3. Expression of MHC class I determinants on erythrocytes of SLE patients.
Giles CM; Walport MJ; David J; Darke C
Clin Exp Immunol; 1987 Aug; 69(2):368-74. PubMed ID: 3308228
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum level of soluble HLA class I antigens in patients with systemic lupus erythematosus.
Tsuchiya N; Shiota M; Yamaguchi A; Ito K
Arthritis Rheum; 1996 May; 39(5):792-6. PubMed ID: 8639176
[TBL] [Abstract][Full Text] [Related]
5. The rate of loss of CR1 from ageing erythrocytes in vivo in normal subjects and SLE patients: no correlation with structural or numerical polymorphisms.
Moldenhauer F; Botto M; Walport MJ
Clin Exp Immunol; 1988 Apr; 72(1):74-8. PubMed ID: 2899464
[TBL] [Abstract][Full Text] [Related]
6. Coexistent rheumatoid arthritis and systemic lupus erythematosus: clinical, serological, and phenotypic features.
Brand CA; Rowley MJ; Tait BD; Muirden KD; Whittingham SF
Ann Rheum Dis; 1992 Feb; 51(2):173-6. PubMed ID: 1550399
[TBL] [Abstract][Full Text] [Related]
7. Erythroid HLA class I expression in 300 patients with haematological, renal and rheumatological disorders.
Ranasinghe WA; Giles CM; Pusey CD; Hows J; Ritter MA; Walport MJ
Vox Sang; 1990; 59(1):55-9. PubMed ID: 2396373
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of serum soluble HLA class I antigens in systemic lupus erythematosus.
Hagihara M; Shimura T; Yamamoto K; Sujirachato K; Tsuji S; Yamamura M; Tsuji K
Tokai J Exp Clin Med; 1993 Jun; 18(1-2):61-4. PubMed ID: 7940609
[TBL] [Abstract][Full Text] [Related]
9. HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus.
Rizzo R; Hviid TV; Govoni M; Padovan M; Rubini M; Melchiorri L; Stignani M; Carturan S; Grappa MT; Fotinidi M; Ferretti S; Voss A; Laustrup H; Junker P; Trotta F; Baricordi OR
Tissue Antigens; 2008 Jun; 71(6):520-9. PubMed ID: 18380776
[TBL] [Abstract][Full Text] [Related]
10. A study of HLA (Bg) on red cells and platelets by immunoblotting with monoclonal antibodies.
Giles CM; Botto M; King MJ
Transfusion; 1990 Feb; 30(2):126-32. PubMed ID: 1689515
[TBL] [Abstract][Full Text] [Related]
11. Soluble HLA-I (s-HLA-I) synthesis in systemic lupus erythematosus.
Adamashvili I; Wolf R; Aultman D; Milford EL; Jaffe S; Hall V; Pressly T; Minagar A; Kelley R
Rheumatol Int; 2003 Nov; 23(6):294-300. PubMed ID: 12879264
[TBL] [Abstract][Full Text] [Related]
12. Systemic lupus erythematosus, rheumatoid arthritis and HLA phenotypes in Jamaicans.
Smikle MF; Barton EN; DeCeulaer K; Williams WN; James OB
West Indian Med J; 1995 Mar; 44(1):11-3. PubMed ID: 7793105
[TBL] [Abstract][Full Text] [Related]
13. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
[TBL] [Abstract][Full Text] [Related]
14. HLA class I (Bg) antigens on red cells of SLE patients: a serological study with polyclonal and monoclonal antibodies.
Giles CM; Darke C; Rowe GP; Botto M
Vox Sang; 1989; 56(4):254-61. PubMed ID: 2763504
[TBL] [Abstract][Full Text] [Related]
15. Association between DR antigens, rheumatoid arthritis with and without extraarticular features and systemic lupus erythematosus in northern Italy.
Ferraccioli G; Savi M
J Rheumatol; 1988 Jan; 15(1):51-3. PubMed ID: 3258384
[TBL] [Abstract][Full Text] [Related]
16. Roles of 1,25(OH)2D3 and Vitamin D Receptor in the Pathogenesis of Rheumatoid Arthritis and Systemic Lupus Erythematosus by Regulating the Activation of CD4+ T Cells and the PKCĪ“/ERK Signaling Pathway.
He XJ; Ding Y; Xiang W; Dang XQ
Cell Physiol Biochem; 2016; 40(3-4):743-756. PubMed ID: 27915349
[TBL] [Abstract][Full Text] [Related]
17. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
[TBL] [Abstract][Full Text] [Related]
18. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
Ross GD; Yount WJ; Walport MJ; Winfield JB; Parker CJ; Fuller CR; Taylor RP; Myones BL; Lachmann PJ
J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the prevalence and clinical associations of antibodies to human fibronectin in systemic lupus erythematosus.
Atta MS; Lim KL; Ala'deen DA; Powell RJ; Todd I
Ann Rheum Dis; 1995 Feb; 54(2):117-24. PubMed ID: 7702398
[TBL] [Abstract][Full Text] [Related]
20. Increased frequency of class I and II anti-human leukocyte antigen antibodies in systemic lupus erythematosus and scleroderma and associated factors: a comparative study.
Tozkir H; Pamuk ON; Duymaz J; Gurkan H; Yazar M; Sari G; Tanrikulu H; Pamuk GE
Int J Rheum Dis; 2016 Dec; 19(12):1304-1309. PubMed ID: 25292400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
